Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Clinical Trial With SCIT in Patients With Rhinitis/Rhinoconjunctivitis With or Without Mild to Moderate Asthma Sensitized to Dpt. and/or D. Farinae

NCT04435990 is registered in ClinicalTrials.gov with Inmunotek S.L. as lead sponsor.

NCT NCT04435990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04435990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Clinical Trial With SCIT in Patients With Rhinitis/Rhinoconjunctivitis With or Without Mild to Moderate Asthma Sensitized to Dpt. and/or D. Farinae
Lead sponsor
Inmunotek S.L.
Phase
Phase 3
Overall status
Recruiting
Start date
October 6, 2020
Completion date
December 31, 2026
Enrollment
150 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, allergic, rhinitis, allergic, rhinoconjunctivitis